Dense-core senile plaques in the Flemish variant of Alzheimer's disease are vasocentric.

Alzheimer's disease (AD) is characterized by deposition of beta-amyloid (Abeta) in diffuse and senile plaques, and variably in vessels. Mutations in the Abeta-encoding region of the amyloid precursor protein (APP) gene are frequently associated with very severe forms of vascular Abeta deposition, sometimes also accompanied by AD pathology. We earlier described a Flemish APP (A692G) mutation causing a form of early-onset AD with a prominent cerebral amyloid angiopathy and unusually large senile plaque cores. The pathogenic basis of Flemish AD is unknown. By image and mass spectrometric Abeta analyses, we demonstrated that in contrast to other familial AD cases with predominant brain Abeta42, Flemish AD patients predominantly deposit Abeta40. On serial histological section analysis we further showed that the neuritic senile plaques in APP692 brains were centered on vessels. Of a total of 2400 senile plaque cores studied from various brain regions from three patients, 68% enclosed a vessel, whereas the remainder were associated with vascular walls. These observations were confirmed by electron microscopy coupled with examination of serial semi-thin plastic sections, as well as three-dimensional observations by confocal microscopy. Diffuse plaques did not associate with vessels, or with neuritic or inflammatory pathology. Together with earlier in vitro data on APP692, our analyses suggest that the altered biological properties of the Flemish APP and Abeta facilitate progressive Abeta deposition in vascular walls that in addition to causing strokes, initiates formation of dense-core senile plaques in the Flemish variant of AD.

[1]  H. Vinters,et al.  Point Substitution in the Central Hydrophobic Cluster of a Human β-Amyloid Congener Disrupts Peptide Folding and Abolishes Plaque Competence† , 1996 .

[2]  B. Greenberg,et al.  Mutant and native human beta-amyloid precursor proteins in transgenic mouse brain. , 1995, Neurobiology of aging.

[3]  T. Miyakawa,et al.  The relationship between senile plaques and cerebral blood vessels in Alzheimer’s disease and senile dementia , 1982, Virchows Archiv. B, Cell pathology including molecular pathology.

[4]  R. Roos,et al.  Secondary microvascular degeneration in amyloid angiopathy of patients with hereditary cerebral hemorrhage with amyloidosis, Dutch type (HCHWA-D) , 1998, Acta Neuropathologica.

[5]  F. Tagliavini,et al.  Parenchymal preamyloid and amyloid deposits in the brains of patients with hereditary cerebral hemorrhage with amyloidosis—Dutch type , 1990, Neuroscience Letters.

[6]  H. Akiyama,et al.  White matter amyloid in Alzheimer's disease brain , 2004, Acta Neuropathologica.

[7]  H. Braak,et al.  Neuropathological stageing of Alzheimer-related changes , 2004, Acta Neuropathologica.

[8]  Yu-Min Kuo,et al.  Cerebral amyloid angiopathy: amyloid beta accumulates in putative interstitial fluid drainage pathways in Alzheimer's disease. , 1998, The American journal of pathology.

[9]  B T Hyman,et al.  Senile dementia associated with amyloid beta protein angiopathy and tau perivascular pathology but not neuritic plaques in patients homozygous for the APOE-epsilon4 allele. , 2000, Acta neuropathologica.

[10]  J. Weyler,et al.  EVALUATION OF TUMOUR ANGIOGENESIS AS A PROGNOSTIC MARKER IN MALIGNANT MESOTHELIOMA , 1997, The Journal of pathology.

[11]  F. Tagliavini,et al.  Ubiquitinated neurites are associated with preamyloid and cerebral amyloid β deposits in patients with hereditary cerebral hemorrhage with amyloidosis Dutch type , 2004, Acta Neuropathologica.

[12]  D. Mann,et al.  Amyloid β protein (Aβ) deposition: Aβ42(43) precedes Aβ40 in down Syndrome , 1995, Annals of neurology.

[13]  John Hardy,et al.  Amyloid, the presenilins and Alzheimer's disease , 1997, Trends in Neurosciences.

[14]  C. Schnitzler,et al.  BACE2, a beta -secretase homolog, cleaves at the beta site and within the amyloid-beta region of the amyloid-beta precursor protein. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[15]  C. Broeckhoven,et al.  Flemish and Dutch Mutations in Amyloid β Precursor Protein Have Different Effects on Amyloid β Secretion , 1998, Neurobiology of Disease.

[16]  C. van Broeckhoven,et al.  The apolipoprotein E ε4 allele does not influence the clinical expression of the amyloid precursor protein gene codon 693 or 692 mutations , 1994, Annals of neurology.

[17]  C. Cotman,et al.  Amino-terminal deletions enhance aggregation of beta-amyloid peptides in vitro. , 1995, The Journal of biological chemistry.

[18]  Carl W. Cotman,et al.  Amino-terminal Deletions Enhance Aggregation of β-Amyloid Peptides in Vitro(*) , 1995, The Journal of Biological Chemistry.

[19]  T. Wisniewski,et al.  Peptides homologous to the amyloid protein of Alzheimer's disease containing a glutamine for glutamic acid substitution have accelerated amyloid fibril formation. , 1991, Biochemical and biophysical research communications.

[20]  A. Hofman,et al.  Presentation of amyloidosis in carriers of the codon 692 mutation in the amyloid precursor protein gene (APP692). , 2000, Brain : a journal of neurology.

[21]  A. Larner.  Hypothesis: amyloid beta-peptides truncated at the N-terminus contribute to the pathogenesis of Alzheimer's disease. , 1999, Neurobiology of aging.

[22]  T. Mandybur.  The incidence of cerebral amyloid angiopathy in Alzheimer's disease , 1975, Neurology.

[23]  Y. Ihara,et al.  Diffuse plaques associated with astroglial amyloid β protein, possibly showing a disappearing stage of senile plaques , 1998, Acta Neuropathologica.

[24]  B. Hyman,et al.  Analysis of Cerebral Amyloid Angiopathy in a Transgenic Mouse Model of Alzheimer Disease Using In Vivo Multiphoton Microscopy , 2001, Journal of neuropathology and experimental neurology.

[25]  D. Selkoe,et al.  Fibril formation by primate, rodent, and Dutch-hemorrhagic analogues of Alzheimer amyloid beta-protein. , 1992, Biochemistry.

[26]  B. Greenberg,et al.  Mutant and native human β-amyloid precursor proteins in transgenic mouse brain , 1995, Neurobiology of Aging.

[27]  P. E. Briët,et al.  Hereditary cerebral hemorrhage with amyloidosis — Dutch type , 1989, Clinical Neurology and Neurosurgery.

[28]  Ralph A. Nixon,et al.  Aβ peptide immunization reduces behavioural impairment and plaques in a model of Alzheimer's disease , 2000, Nature.

[29]  R. Kalaria,et al.  The relationship of amyloid plaques to cerebral capillaries in Alzheimer's disease. , 1990, The American journal of pathology.

[30]  H. Vanderstichele,et al.  Nonfibrillar diffuse amyloid deposition due to a γ 42-secretase site mutation points to an essential role for N-truncated A β 42 in Alzheimer ’ s disease , 2000 .

[31]  J. Wegiel,et al.  Ultrastructural studies of the cells forming amyloid in the cortical vessel wall in Alzheimer's disease , 2004, Acta Neuropathologica.

[32]  Larner Aj.  Hypothesis: amyloid beta-peptides truncated at the N-terminus contribute to the pathogenesis of Alzheimer's disease. , 1999 .

[33]  P. S. St George-Hyslop,et al.  A beta peptide immunization reduces behavioural impairment and plaques in a model of Alzheimer's disease. , 2000, Nature.

[34]  I. Tooyama,et al.  Columnar arrangement of beta-amyloid protein deposits in the cerebral cortex of patients with Alzheimer's disease. , 1993, Acta neuropathologica.

[35]  P. Schofield,et al.  Variable phenotype of Alzheimer’s disease with spastic paraparesis , 2007, Annals of neurology.

[36]  D. Selkoe,et al.  In vitro studies of amyloid beta-protein fibril assembly and toxicity provide clues to the aetiology of Flemish variant (Ala692-->Gly) Alzheimer's disease. , 2001, The Biochemical journal.

[37]  D. Walsh,et al.  Effects of the mutations Glu22 to Gln and Ala21 to Gly on the aggregation of a synthetic fragment of the Alzheimer's amyloid β/A4 peptide , 1993, Neuroscience Letters.

[38]  Mutation of the Alzheimer's disease amyloid gene in hereditary cerebral hemorrhage, Dutch type. , 1990, Science.

[39]  S. Edland,et al.  in Alzheimer's Disease , 1994 .

[40]  H. Arai,et al.  Distribution of amyloid deposits in the cerebral white matter of the Alzheimer’s disease brain: relationship to blood vessels , 1997, Acta Neuropathologica.

[41]  J. Geddes,et al.  Toxicity of pyroglutaminated amyloid beta-peptides 3(pE)-40 and -42 is similar to that of A beta1-40 and -42. , 1999, Journal of neurochemistry.

[42]  M J Ball,et al.  beta-Amyloid-(1-42) is a major component of cerebrovascular amyloid deposits: implications for the pathology of Alzheimer disease. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[43]  T. Grabowski,et al.  Novel amyloid precursor protein mutation in an Iowa family with dementia and severe cerebral amyloid angiopathy , 2001, Annals of neurology.

[44]  B. Ghetti,et al.  Neurobiology: Presenilin-1 mutations in Alzheimer's disease , 2000, Nature.

[45]  B. Winblad,et al.  Predominant deposition of amyloid-beta 42(43) in plaques in cases of Alzheimer's disease and hereditary cerebral hemorrhage associated with mutations in the amyloid precursor protein gene. , 1996, The American journal of pathology.

[46]  H. Yamaguchi,et al.  Age-related plaque morphology and C-terminal heterogeneity of amyloid β in Dutch-type hereditary cerebral hemorrhage with amyloidosis , 2000, Acta Neuropathologica.

[47]  P. Lansbury,et al.  Seeding “one-dimensional crystallization” of amyloid: A pathogenic mechanism in Alzheimer's disease and scrapie? , 1993, Cell.

[48]  D. Selkoe,et al.  The cell biology of β-amyloid precursor protein and presenilin in Alzheimer's disease , 1998 .

[49]  J. C. Torre,et al.  Critical threshold cerebral hypoperfusion causes Alzheimer’s disease? , 1999, Acta Neuropathologica.

[50]  R. Roos,et al.  Dementia in hereditary cerebral hemorrhage with amyloidosis‐Dutch type is associated with cerebral amyloid angiopathy but is independent of plaques and neurofibrillary tangles , 2001, Annals of neurology.

[51]  A. Hofman,et al.  Presenile dementia and cerebral haemorrhage linked to a mutation at codon 692 of the β–amyloid precursor protein gene , 1992, Nature Genetics.

[52]  T. Miyakawa,et al.  Role of Blood Vessels in Producing Pathological Changes in the Brain with Alzheimer's Disease , 2000, Annals of the New York Academy of Sciences.

[53]  D. Selkoe,et al.  Effects of the amyloid precursor protein Glu693-->Gln 'Dutch' mutation on the production and stability of amyloid beta-protein. , 1999, The Biochemical journal.

[54]  A. Hofman,et al.  Presenile Alzheimer dementia characterized by amyloid angiopathy and large amyloid core type senile plaques in the APP 692Ala→Gly mutation , 1998, Acta Neuropathologica.

[55]  B Frangione,et al.  Substitutions at codon 22 of Alzheimer's abeta peptide induce diverse conformational changes and apoptotic effects in human cerebral endothelial cells. , 2000, The Journal of biological chemistry.

[56]  R O Weller,et al.  Cerebral amyloid angiopathy: amyloid beta accumulates in putative interstitial fluid drainage pathways in Alzheimer's disease. , 1998, The American journal of pathology.

[57]  G. Glenner.  Amyloid deposits and amyloidosis. The beta-fibrilloses (first of two parts). , 1980, The New England journal of medicine.

[58]  D. Mann,et al.  Amyloid angiopathy and variability in amyloid beta deposition is determined by mutation position in presenilin-1-linked Alzheimer's disease. , 2001, The American journal of pathology.

[59]  M. Ball,et al.  Chemical characterization of A beta 17-42 peptide, a component of diffuse amyloid deposits of Alzheimer disease. , 1994, The Journal of biological chemistry.

[60]  B. Winblad,et al.  A pathogenic mutation for probable Alzheimer's disease in the APP gene at the N–terminus of β–amyloid , 1992, Nature Genetics.

[61]  J. Hardy,et al.  Amyloid beta protein precursor gene and hereditary cerebral hemorrhage with amyloidosis (Dutch). , 1990, Science.

[62]  C. van Broeckhoven,et al.  Flemish and Dutch mutations in amyloid beta precursor protein have different effects on amyloid beta secretion. , 1998, Neurobiology of disease.

[63]  C. Broeckhoven,et al.  Behavioral Disturbances without Amyloid Deposits in Mice Overexpressing Human Amyloid Precursor Protein with Flemish (A692G) or Dutch (E693Q) Mutation , 2000, Neurobiology of Disease.

[64]  H. Akiyama,et al.  Immunohistochemical localization of amyloid β-protein with amino-terminal aspartate in the cerebral cortex of patients with Alzheimer's disease , 1999, Brain Research.

[65]  D. Dickson,et al.  The Pathogenesis of Senile Plaques , 1997, Journal of neuropathology and experimental neurology.

[66]  M. Cruts,et al.  Cerebral amyloid angiopathy is a pathogenic lesion in Alzheimer's disease due to a novel presenilin 1 mutation. , 2001, Brain : a journal of neurology.

[67]  Bradley T. Hyman,et al.  Senile dementia associated with amyloid β protein angiopathy and tau perivascular pathology but not neuritic plaques in patients homozygous for the APOE-ε4 allele , 2000, Acta Neuropathologica.

[68]  D. Walsh,et al.  Aggregation and Metal‐Binding Properties of Mutant Forms of the Amyloid Aβ Peptide of Alzheimer's Disease , 1996, Journal of neurochemistry.

[69]  T. Iwatsubo,et al.  Visualization of Aβ42(43) and Aβ40 in senile plaques with end-specific Aβ monoclonals: Evidence that an initially deposited species is Aβ42(43) , 1994, Neuron.

[70]  B. Sommer,et al.  Neuronal overexpression of mutant amyloid precursor protein results in prominent deposition of cerebrovascular amyloid. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[71]  S. Younkin,et al.  An increased percentage of long amyloid beta protein secreted by familial amyloid beta protein precursor (beta APP717) mutants. , 1994, Science.

[72]  W. V. Van Nostrand,et al.  Amyloid β-Protein Aggregation Nullifies Its Pathologic Properties in Cultured Cerebrovascular Smooth Muscle Cells (*) , 1995, The Journal of Biological Chemistry.

[73]  I. Tooyama,et al.  Columnar arragement of β-amyloid protein deposits in the cerebral cortex of patients with Alzheimer's disease , 2004, Acta Neuropathologica.

[74]  D. Selkoe,et al.  Mutations associated with a locus for familial Alzheimer's disease result in alternative processing of amyloid beta-protein precursor. , 1994, The Journal of biological chemistry.

[75]  D. Drachman,et al.  Vascular amyloid deposition in Alzheimer's disease. Neither necessary nor sufficient for the local formation of plaques or tangles. , 1993, Archives of neurology.

[76]  H. Vinters,et al.  Toxicity of Dutch (E22Q) and Flemish (A21G) mutant amyloid beta proteins to human cerebral microvessel and aortic smooth muscle cells. , 2000, Stroke.

[77]  C. Schnitzler,et al.  BACE2, a β-secretase homolog, cleaves at the β site and within the amyloid-β region of the amyloid-β precursor protein , 2000 .

[78]  H. Wiśniewski,et al.  Spectrum of morphological appearance of amyloid deposits in Alzheimer's disease , 2004, Acta Neuropathologica.

[79]  J. Geddes,et al.  Toxicity of Pyroglutaminated Amyloid β‐Peptides 3(pE)‐40 and ‐42 Is Similar to That of Aβ1‐40 and ‐42 , 1999 .

[80]  H. Arai,et al.  An immunohistochemical study of β-protein in Alzheimer-type dementia brains , 1989, Journal of Neurology.

[81]  S. Younkin,et al.  The 'Arctic' APP mutation (E693G) causes Alzheimer's disease by enhanced Aβ protofibril formation , 2001, Nature Neuroscience.

[82]  H. Vinters,et al.  Point substitution in the central hydrophobic cluster of a human beta-amyloid congener disrupts peptide folding and abolishes plaque competence. , 1996, Biochemistry.

[83]  J. Davis-Salinas,et al.  Amyloid β‐Protein Induces the Cerebrovascular Cellular Pathology of Alzheimer's Disease and Related Disorders a , 1996 .

[84]  H. Arai,et al.  An immunohistochemical study of beta-protein in Alzheimer-type dementia brains. , 1989, Journal of neurology.

[85]  G. Glenner,et al.  Congophilic angiopathy in the pathogenesis of Alzheimer's degeneration. , 1981, Annales de pathologie.

[86]  Z. Khachaturian.  Diagnosis of Alzheimer's disease. , 1985, Archives of neurology.

[87]  S. Gandy,et al.  The profile of soluble amyloid beta protein in cultured cell media. Detection and quantification of amyloid beta protein and variants by immunoprecipitation-mass spectrometry. , 1996, The Journal of biological chemistry.